{"id":60656,"date":"2024-02-28T07:01:04","date_gmt":"2024-02-28T07:01:04","guid":{"rendered":"https:\/\/medsname.com\/valprol-cr\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"valprol-cr","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/valprol-cr\/","title":{"rendered":"Valprol-CR"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">&#9889; Quick Answer &mdash; What is Valprol-CR?<\/h3>\n<p style=\"margin:0;\"><strong>Valprol-CR<\/strong> este un <strong>controlled-release tablet<\/strong> from Intas Pharmaceuticals containing <strong>sodium valproate + valproic acid<\/strong> &mdash; a broad-spectrum anti-epileptic, mood stabiliser and migraine-prophylaxis drug. Available in <strong>200 mg and 750 mg<\/strong> CR strengths. Used for: <strong>multiple tipuri de crize epileptice<\/strong> (tonico-clonice generalizate, absen\u021be, mioclonice, par\u021biale), <strong>mania acut\u0103 \u00een tulburarea bipolar\u0103 tip I<\/strong>, \u0219i <strong>profilaxia migrenei<\/strong>. Adult dosing: 600&ndash;2,500 mg\/day in divided doses. Take with or after food to reduce GI upset. <strong>FDA Categorie de sarcin\u0103 X pentru migrene, Categorie D pentru epilepsie<\/strong> &mdash; one of the most teratogenic drugs in routine clinical use. Women of childbearing potential need explicit pregnancy-prevention counselling and should usually avoid valproate unless other options have failed. Mandatory monitoring: <strong>baseline + periodic LFTs, FBC, ammonia level if symptomatic<\/strong>. Never stop abruptly &mdash; abrupt discontinuation can precipitate status epilepticus.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">What Is Valprol-CR?<\/h2>\n<p>Valprol-CR is an oral controlled-release tablet from Intas Pharmaceuticals containing <strong>sodium valproate<\/strong> in combination with <strong>valproic acid<\/strong> (the same active molecule, different salt form &mdash; in solution they are equivalent). The CR (controlled-release) formulation gradually releases the active over 12&ndash;24 hours, allowing once-daily or twice-daily dosing instead of the three-or-four-times-daily schedule needed with immediate-release valproate.<\/p>\n<p>Valproate is one of the oldest and most broad-spectrum anti-epileptic drugs in use. It is licensed for multiple seizure types in epilepsy, acute mania in bipolar I disorder, and migraine prophylaxis. The CR formulation is preferred for adults requiring sustained 24-hour drug levels &mdash; particularly those who experience peak-related side effects (drowsiness, tremor) on immediate-release valproate.<\/p>\n<h2 class=\"wp-block-heading\">How Does Valprol-CR Work?<\/h2>\n<p>Sodium valproate has multiple complementary mechanisms that together produce its broad-spectrum anti-seizure and mood-stabilising effects:<\/p>\n<ul>\n<li><strong>Blocarea canalelor de sodiu dependente de voltaj<\/strong> &mdash; reduces high-frequency neuronal firing, the basis of its anti-seizure effect on partial and generalised tonic-clonic seizures.<\/li>\n<li><strong>Inhibarea canalelor de calciu tip T<\/strong> &mdash; particularly relevant to absence seizures, where T-type calcium currents in thalamocortical neurons drive the spike-wave pattern.<\/li>\n<li><strong>\u00cent\u0103rirea sistemului GABAergic<\/strong> &mdash; raises brain GABA concentration through inhibition of GABA-degrading enzymes (GABA-T and succinic semialdehyde dehydrogenase) and increased GABA synthesis.<\/li>\n<li><strong>Modularea receptorului NMDA<\/strong> &mdash; reduces excitatory glutamate transmission.<\/li>\n<\/ul>\n<p>Efectul combinat este un spectru terapeutic larg pentru diferite tipuri de crize, activitate stabilizatoare a dispozi\u021biei \u00een tulburarea bipolar\u0103 tip I \u0219i profilaxie a migrenei prin suprimarea depresiunii corticale de r\u0103sp\u00e2ndire.<\/p>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n<ul>\n<li><strong>Epilepsie \u2014 crize tonic-clonice generalizate<\/strong> (prim\u0103 linie)<\/li>\n<li><strong>Epilepsie \u2014 crize de absen\u021b\u0103<\/strong> (first-line, especially in childhood and juvenile-onset)<\/li>\n<li><strong>Epilepsie \u2014 crize mioclonice<\/strong> (linie de prim\u0103 inten\u021bie pentru epilepsia mioclonic\u0103 juvenil\u0103)<\/li>\n<li><strong>Epilepsie \u2014 crize par\u021biale (focale)<\/strong> (cu sau f\u0103r\u0103 generalizare secundar\u0103)<\/li>\n<li><strong>sindromul Lennox-Gastaut<\/strong> \u0219i alte tipuri mixte de crize<\/li>\n<li><strong>Tulburare bipolar\u0103 tip I \u2014 manie acut\u0103<\/strong> (monoterapie aprobat\u0103 de FDA)<\/li>\n<li><strong>Tulburare bipolar\u0103 de tip I \u2014 terapie de \u00eentre\u021binere<\/strong> (off-label, utilizat pe scar\u0103 larg\u0103)<\/li>\n<li><strong>Profilaxia migrenei<\/strong> in adults (FDA-approved when migraines are frequent and disabling)<\/li>\n<li><strong>Off-label:<\/strong> behavioural agitation in dementia (no longer recommended &mdash; mortality signal), aggression and impulse control, neuropathic pain<\/li>\n<\/ul>\n<p>Valprol-CR is <strong>prime\u0219te,<\/strong> first-line for: women of childbearing potential who could become pregnant (because of teratogenicity), pure absence seizures in young children if ethosuximide is available (cleaner safety), or generalised anxiety \/ unipolar depression. <strong>Behavioural agitation in dementia is no longer a recommended use<\/strong> &mdash; observational data suggest increased mortality, similar to the antipsychotic-in-dementia signal.<\/p>\n<h2 class=\"wp-block-heading\">Valprol-CR Dosage and How to Take<\/h2>\n<p>Valprol-CR comes at <strong>200 mg<\/strong> \u0219i <strong>750 mg<\/strong> controlled-release strengths.<\/p>\n<p><strong>Doze standard pentru adul\u021bi pe indica\u021bie:<\/strong><\/p>\n<ul>\n<li><strong>Epilepsie:<\/strong> Start 600 mg\/day (300 mg twice daily). Increase by 200 mg every 3 days based on seizure control. Maintenance 1,000&ndash;2,000 mg\/day in 1&ndash;2 divided doses. Maximum 2,500 mg\/day.<\/li>\n<li><strong>Bipolar I (mania acut\u0103):<\/strong> Start 750 mg\/day in divided doses; increase rapidly to achieve serum level 50&ndash;125 &micro;g\/mL. Maintenance 1,000&ndash;2,500 mg\/day.<\/li>\n<li><strong>Profilaxia migrenei:<\/strong> Start 250 mg twice daily; increase to 500&ndash;1,000 mg\/day if needed. Many patients respond at 500 mg\/day.<\/li>\n<\/ul>\n<h3 class=\"wp-block-heading\">How to Take Valprol-CR Properly<\/h3>\n<ol>\n<li><strong>Lua\u021bi \u00een timpul sau dup\u0103 mas\u0103.<\/strong> This is the single biggest factor in GI tolerability. Empty-stomach dosing causes nausea, dyspepsia and abdominal pain in most patients.<\/li>\n<li><strong>\u00cenghi\u021bi\u021bi \u00eentreaga tablet\u0103 cu ap\u0103.<\/strong> Do NOT crush, split, or chew controlled-release tablets &mdash; this destroys the controlled-release mechanism and causes a dose dump that produces severe peak-related side effects (drowsiness, tremor, GI upset).<\/li>\n<li><strong>Twice daily for most adults<\/strong>, ideally morning + evening 12 hours apart. Once-daily dosing (full daily dose at bedtime) is reasonable for migraine prophylaxis at 500&ndash;1,000 mg\/day.<\/li>\n<li><strong>Fi\u021bi consecven\u021bi cu orarul.<\/strong> Missed doses produce noticeable trough levels. If a dose is missed and remembered within 6 hours, take it. If &gt;6 hours, skip and resume normally &mdash; do not double-dose.<\/li>\n<li><strong>Program de monitorizare:<\/strong> baseline LFTs (AST, ALT, GGT), full blood count, and platelet count <strong>before starting<\/strong>. Repeat at <strong>1 month<\/strong>, <strong>3 luni<\/strong>, <strong>6 luni<\/strong>, then annually. Check ammonia level if patient develops drowsiness, confusion or vomiting.<\/li>\n<li><strong>Monitorizarea terapeutic\u0103 a medicamentelor:<\/strong> serum valproate trough level is useful in epilepsy (target 50&ndash;100 &micro;g\/mL) and bipolar (target 50&ndash;125 &micro;g\/mL). Not routinely needed for migraine prophylaxis.<\/li>\n<li><strong>Nu \u00eenceta\u021bi brusc.<\/strong> \u00centreruperea brusc\u0103 \u00een epilepsie poate precipita <strong>stare epileptic\u0103<\/strong> (medical emergency) even in patients who have been seizure-free for years. Taper over 2&ndash;6 weeks under medical supervision when discontinuing.<\/li>\n<li><strong>Prevenirea sarcinii<\/strong> (women of childbearing potential): use reliable contraception throughout treatment. Discuss alternative drugs if pregnancy is a possibility &mdash; valproate is one of the most teratogenic drugs in routine clinical use.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Side Effects of Valprol-CR<\/h2>\n<p><strong>Frecvente (adesea legate de doz\u0103, pot disp\u0103rea cu titrare mai lent\u0103):<\/strong><\/p>\n<ul>\n<li>Grea\u021b\u0103, v\u0103rs\u0103turi, dispepsie, dureri abdominale<\/li>\n<li>Somnolen\u021b\u0103, oboseal\u0103<\/li>\n<li>Tremor (fine, postural &mdash; often dose-dependent)<\/li>\n<li>Weight gain (10&ndash;20% of patients gain &gt;5 kg)<\/li>\n<li>Hair thinning or hair loss (reversible on discontinuation)<\/li>\n<li>Diaree sau constipa\u021bie<\/li>\n<li>Cre\u0219terea apetitului<\/li>\n<\/ul>\n<p><strong>Mai pu\u021bin frecvente, dar importante:<\/strong><\/p>\n<ul>\n<li>Thrombocytopenia (low platelet count) &mdash; usually mild and dose-related; check FBC every visit<\/li>\n<li>Hyperammonaemic encephalopathy &mdash; drowsiness, confusion, vomiting; can occur with normal LFTs; check ammonia level if suspected<\/li>\n<li>Polycystic ovary syndrome features in women &mdash; hyperandrogenism, menstrual irregularity, weight gain<\/li>\n<li>Increased liver enzymes (often asymptomatic)<\/li>\n<li>Pancreatit\u0103 (rar\u0103, dar poten\u021bial letal\u0103)<\/li>\n<li>\u00cencetinire cognitiv\u0103, dificult\u0103\u021bi de memorie<\/li>\n<\/ul>\n<p><strong>Rare dar necesita\u021bi aten\u021bie medical\u0103 imediat\u0103:<\/strong><\/p>\n<ul>\n<li><strong>Acute fulminant hepatic failure<\/strong> &mdash; particularly in children under 2 years on polypharmacy. Stop immediately if jaundice, severe vomiting or new lethargy develops.<\/li>\n<li><strong>Pancreatit\u0103 acut\u0103<\/strong> &mdash; severe abdominal pain, vomiting<\/li>\n<li><strong>Encefalopatie hiperamonemic\u0103<\/strong> with normal LFTs &mdash; new confusion, drowsiness, vomiting<\/li>\n<li>Reac\u021bii cutanate severe (sindromul Stevens-Johnson, DRESS)<\/li>\n<li>Supresie de m\u0103duv\u0103 osoas\u0103<\/li>\n<li>Hemoragii severe din cauza trombocitopeniei sau disfunc\u021biei plachetare<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Avertismente \u0219i Precau\u021bii \u2014 CRITICAL<\/h2>\n<ul>\n<li><strong>Pregnancy: ABSOLUTE CONTRAINDICATION for migraine (FDA Category X) and STRONG WARNING for epilepsy (Category D).<\/strong> Sodium valproate is one of the most potent human teratogens in routine clinical use. Risk of major congenital malformations (neural tube defects, craniofacial defects, cardiac defects, limb defects, hypospadias) is approximately <strong>10%<\/strong>, plus a 30&ndash;40% risk of significant neurodevelopmental impairment (lower IQ, autism spectrum disorder) in children exposed in utero. Use only if no other option is effective. Women of childbearing potential need: (1) explicit pregnancy-prevention counselling, (2) reliable contraception throughout treatment, (3) preconception folate supplementation 5 mg\/day if pregnancy is planned, (4) urgent specialist review if pregnancy occurs.<\/li>\n<li><strong>Hepatotoxicitate:<\/strong> highest risk in children under 2 years on multiple anti-epileptics (rare in adult monotherapy). Stop immediately for jaundice, severe vomiting, lethargy, or worsening seizures.<\/li>\n<li><strong>Pancreatit\u0103:<\/strong> rare but life-threatening; idiosyncratic, can occur at any time during treatment. Seek emergency care for severe abdominal pain.<\/li>\n<li><strong>Hyperammonaemic encephalopathy:<\/strong> can occur with normal LFTs &mdash; check ammonia level if patient develops drowsiness, confusion or vomiting on valproate.<\/li>\n<li><strong>Boal\u0103 mitocondrial\u0103 (muta\u021bii POLG):<\/strong> absolute contraindication &mdash; valproate causes acute liver failure in this rare population. Genetic testing is appropriate before starting if there is family history of mitochondrial disease or unexplained liver disease.<\/li>\n<li><strong>Tulbur\u0103ri ale ciclului ureic:<\/strong> contraindication &mdash; valproate precipitates hyperammonaemic encephalopathy.<\/li>\n<li><strong>Riscul de s\u00e2ngerare:<\/strong> valproate impairs platelet function and may cause thrombocytopenia. Tell the surgeon and stop 1&ndash;2 weeks before elective surgery if possible.<\/li>\n<li><strong>Pacien\u021bi cu demen\u021b\u0103:<\/strong> off-label use for behavioural agitation is no longer recommended &mdash; observational data show increased mortality.<\/li>\n<li><strong>Nu \u00eentrerupe\u021bi brusc<\/strong> in epilepsy &mdash; can precipitate status epilepticus.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindications &mdash; Who Should NOT Take Valprol-CR<\/h2>\n<ul>\n<li>Pregnancy or planning pregnancy (especially for migraine prophylaxis &mdash; absolute contraindication)<\/li>\n<li>Known hypersensitivity to valproate or any tablet excipient<\/li>\n<li>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103 sau boal\u0103 hepatic\u0103 activ\u0103<\/li>\n<li>Personal or family history of severe hepatic dysfunction caused by drugs<\/li>\n<li>Mitochondrial disease (especially POLG mutations)<\/li>\n<li>Tulbur\u0103ri ale ciclului ureic<\/li>\n<li>Porfirie acut\u0103<\/li>\n<li>Children under 2 years (especially on polypharmacy &mdash; high hepatotoxicity risk)<\/li>\n<li>Pancreatit\u0103 activ\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Combina\u021bi cu<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Efect<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Ce s\u0103 face\u021bi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Lamotrigin\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Valproate doubles lamotrigine levels &mdash; markedly increased risk of severe rash and Stevens-Johnson syndrome<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Reduce lamotrigine dose by 50% when combined; very slow titration. Specialist supervision.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Carbapeneme (meropenem, ertapenem, imipenem)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Carbapenems dramatically reduce valproate levels &mdash; can precipitate seizures within days<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Avoid combination. Use alternative antibiotic if valproate is essential.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Phenytoin, carbamazepine, phenobarbital (other AEDs)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Bidirectional protein-binding and metabolism interactions &mdash; unpredictable effects on both drugs<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitoriza\u021bi nivelurile ambelor; supraveghere specializat\u0103.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Aspirin\u0103 (doze mari), AINS<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Displace valproate from albumin; increase free fraction and toxicity<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Evita\u021bi aspirina \u00een doze mari. Monitoriza\u021bi efectele adverse ale valproatului.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Warfarin, anticoagulants<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Increased anticoagulant effect (displacement) and platelet inhibition by valproate<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitor INR more frequently. Watch for bleeding.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Topiramate<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Increased risk of hyperammonaemia and encephalopathy<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Check ammonia level if symptoms develop.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alcool<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Depresie CNS aditiv\u0103 \u0219i hepatotoxicitate<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Limit to occasional small amounts; avoid binge drinking.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Contraceptive orale combinate<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">No significant interaction (unlike many other AEDs)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">COC-urile r\u0103m\u00e2n eficiente. Contraceptia fiabil\u0103 este obligatorie din cauza teratogenit\u0103\u021bii.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Benzodiazepine<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Depresie CNS aditiv\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Avoid routine combination; use lowest doses if combined.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Instruc\u021biuni de Depozitare<\/h2>\n<ul>\n<li>Se p\u0103streaz\u0103 la temperatura camerei, <strong>15\u201325\u00b0C<\/strong>. Proteja\u021bi de lumin\u0103 \u0219i umiditate.<\/li>\n<li>P\u0103stra\u021bi comprimatele \u00een ambalajul original blister p\u00e2n\u0103 la utilizare.<\/li>\n<li>Nu depozita\u021bi \u00een baie \u2014 umiditatea reduce durata de via\u021b\u0103.<\/li>\n<li>Keep out of reach of children &mdash; valproate is highly teratogenic and accidental ingestion by a pregnant household member is a serious risk.<\/li>\n<li>Nu utiliza\u021bi dup\u0103 data de expirare.<\/li>\n<li>Returna\u021bi comprimatele neutilizate la o farmacie pentru eliminarea corespunz\u0103toare.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Alternative conexe pe MedsBase<\/h2>\n<p>Other medications stocked for epilepsy, bipolar disorder and migraine prophylaxis:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/product-category\/neurological-conditions-and-epilepsy\/\">Browse all neurological + epilepsy medications<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/product-category\/mental-health-and-psychiatric-medications\/\">Browse all mental health and psychiatric medications<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/product-category\/anti-migraine\/\">R\u0103sfoi\u021bi medicamentele anti-migren\u0103<\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">What conditions is Valprol-CR used for?<\/h3>\n<p>Valprol-CR (sodium valproate + valproic acid) is licensed for: <strong>multiple tipuri de crize epileptice<\/strong> (tonico-clonice generalizate, absen\u021be, mioclonice, par\u021biale), <strong>mania acut\u0103 \u00een tulburarea bipolar\u0103 tip I<\/strong>, \u0219i <strong>profilaxia migrenei<\/strong> in adults. It is one of the broadest-spectrum anti-epileptic drugs available. Off-label uses include neuropathic pain and behavioural agitation in some psychiatric conditions, but it is no longer recommended for behavioural agitation in dementia (mortality signal in observational data).<\/p>\n<h3 class=\"wp-block-heading\">Why is Valprol-CR so dangerous in pregnancy?<\/h3>\n<p>Sodium valproate is one of the most teratogenic drugs in routine clinical use. In-utero exposure carries approximately <strong>un risc de 10% de malforma\u021bii congenitale majore<\/strong> (neural tube defects, cardiac defects, craniofacial defects, hypospadias, limb defects) plus a <strong>un risc de 30\u201340% de deficien\u021be neurodezvoltamentale semnificative<\/strong> (IQ mai sc\u0103zut, tulburare din spectrul autist). Pentru profilaxia migrenei, FDA \u00eel clasific\u0103 drept <strong>Pregnancy Category X (absolute contraindication)<\/strong>; for epilepsy Category D (use only if benefit outweighs the substantial fetal risk and no other option is available). Women of childbearing potential need explicit counselling, reliable contraception, and 5 mg\/day folate before any planned pregnancy.<\/p>\n<h3 class=\"wp-block-heading\">Why must I never stop Valprol-CR abruptly?<\/h3>\n<p>\u00cen epilepsie, \u00eentreruperea brusc\u0103 poate precipita <strong>stare epileptic\u0103<\/strong> &mdash; a medical emergency where seizures do not stop spontaneously, with significant mortality if untreated. This can happen even in patients who have been seizure-free for years. Always taper over 2&ndash;6 weeks under medical supervision when discontinuing. The same caution applies to bipolar maintenance therapy &mdash; abrupt discontinuation can precipitate a manic relapse.<\/p>\n<h3 class=\"wp-block-heading\">What blood tests do I need on Valprol-CR?<\/h3>\n<p><strong>\u00cenainte de a \u00eencepe:<\/strong> liver function tests (AST, ALT, GGT), full blood count including platelet count, baseline weight, fasting glucose. <strong>\u00cen timpul tratamentului:<\/strong> repeat LFTs and FBC at 1 month, 3 months, 6 months, then annually. <strong>Dac\u0103 nu te sim\u021bi bine:<\/strong> check ammonia level if any new drowsiness, confusion or vomiting (hyperammonaemic encephalopathy can occur with normal LFTs). For epilepsy, periodic serum valproate trough level (target 50&ndash;100 &micro;g\/mL).<\/p>\n<h3 class=\"wp-block-heading\">Why can I not crush or split Valprol-CR tablets?<\/h3>\n<p>The CR (controlled-release) coating is what produces the sustained 12&ndash;24 hour drug release. Crushing or splitting destroys the coating and causes a &#8220;dose dump&#8221; &mdash; the entire dose is absorbed within 2&ndash;3 hours, producing very high peak levels with severe drowsiness, tremor, GI upset and sometimes hyperammonaemic encephalopathy. If a smaller dose is needed, use immediate-release valproate or step down to the 200 mg CR strength rather than splitting a 750 mg CR tablet.<\/p>\n<h3 class=\"wp-block-heading\">Will Valprol-CR cause weight gain or hair loss?<\/h3>\n<p>Ambele sunt frecvente. <strong>Cre\u0219terea \u00een greutate<\/strong> affects 10&ndash;20% of patients (usually 5&ndash;10 kg over the first 6&ndash;12 months) and is driven by increased appetite plus metabolic effects. Mitigate with consistent diet and exercise. <strong>Hair thinning or hair loss<\/strong> afecteaz\u0103 p\u00e2n\u0103 la 10% din pacien\u021bi, de obicei \u00eencepe \u00een primele 3\u20136 luni \u0219i este reversibil\u0103 la reducerea dozei sau \u00eentreruperea tratamentului. Suplimentarea cu zinc \u0219i seleniu este uneori utilizat\u0103 (dovezi limitate).<\/p>\n<h3 class=\"wp-block-heading\">Can Valprol-CR be used with lamotrigine?<\/h3>\n<p>Da, dar cu precau\u021bie extrem\u0103. Valproatul <strong>dubleaz\u0103 nivelurile de lamotrigin\u0103<\/strong> by inhibiting its metabolism, sharply increasing the risk of severe rash and Stevens-Johnson syndrome &mdash; the most serious lamotrigine side effect. The combination is sometimes used (it has good cognitive and seizure-control properties) but lamotrigine must be started at <strong>jum\u0103tate din doza obi\u0219nuit\u0103<\/strong> with a much slower up-titration (12-week protocol). Specialist supervision is essential.<\/p>\n<h3 class=\"wp-block-heading\">Why do certain antibiotics (carbapenems) interact so dangerously with Valprol-CR?<\/h3>\n<p>Antibioticele carbapenemice (meropenem, ertapenem, imipenem) <strong>reduc dramatic nivelurile de valproat<\/strong> &mdash; sometimes by &gt;90% within 1&ndash;3 days &mdash; through a poorly understood mechanism that may involve enterohepatic recirculation. The result is sudden loss of seizure control even in patients on stable therapeutic levels for years. <strong>Evita\u021bi aceast\u0103 combina\u021bie.<\/strong> If a patient on valproate needs a carbapenem (e.g. for hospital-acquired infection), switch the antibiotic to an alternative, OR switch the anti-epileptic before the carbapenem is started.<\/p>\n<h3 class=\"wp-block-heading\">Is Valprol-CR appropriate for behavioural agitation in dementia?<\/h3>\n<p><strong>No longer recommended.<\/strong> Off-label use of valproate for behavioural agitation in Alzheimer&#39;s and other dementias was common until observational studies suggested an <strong>increased mortality signal<\/strong>, similar to the signal that led to black-box warnings on antipsychotic use in dementia. Current guidelines favour non-pharmacological approaches first, then short-term low-dose risperidone or quetiapine if needed, with valproate reserved for very specific cases under specialist supervision.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/gabatop\/\">Gabatop<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/gabimax\/\">Gabimax<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/xepar\/\">Xepar<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tenof-em\/\">Tenof EM<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cresar\/\">Cresar<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Valprol-CR (Sodium valproate CR 200\u2013500 mg) \u2014 anticonvulsant mood stabiliser for epilepsy, bipolar mania, migraine prophylaxis. flatter level curve \u2014 twice-daily controlled-release.<\/p>","protected":false},"featured_media":60657,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3906,3468],"product_tag":[4677,4898,4899],"class_list":{"0":"post-60656","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-mental-health-and-psychiatric-medications","9":"product_cat-neurological-conditions-and-epilepsy","10":"product_tag-sodium-valproate","11":"product_tag-valproic-acid","12":"product_tag-valprol-cr","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/60656","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=60656"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/60657"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=60656"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=60656"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=60656"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=60656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}